These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 6188983)
1. Cystic prolactinoma of the pituitary following surgery for polycystic ovaries. Kurisaka M; Tindall SC; Takei Y Neurol Med Chir (Tokyo); 1983 Jan; 23(1):55-60. PubMed ID: 6188983 [No Abstract] [Full Text] [Related]
2. Pituitary prolactinoma associated with polycystic ovary--case report. Kuroda S; Yonekawa Y; Kawano T Neurol Med Chir (Tokyo); 1991 Nov; 31(11):736-9. PubMed ID: 1723164 [TBL] [Abstract][Full Text] [Related]
3. Craniopharyngioma with hyperprolactinaemia due to a prolactinoma. Wheatley T; Clark JD; Stewart S J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1305-7. PubMed ID: 3794737 [TBL] [Abstract][Full Text] [Related]
4. [Pituitary prolactinoma associated with diabetes mellitus, masked primary hypothyroidism, and polycystic ovary]. Baba T; Kudo M; Kosaka S; Kumagaya Y; Tanaka T Horumon To Rinsho; 1983 Sep; 31(9):929-31. PubMed ID: 6640991 [No Abstract] [Full Text] [Related]
6. Is there a role for targeted medical therapies in patients with craniopharyngiomas? Tritos NA Future Oncol; 2015; 11(24):3221-3. PubMed ID: 26562628 [No Abstract] [Full Text] [Related]
7. The value of prolactin in predicting prolactinοma in hyperprolactinaemic polycystic ovarian syndrome. Kyritsi EM; Dimitriadis GK; Angelousi A; Mehta H; Shad A; Mytilinaiou M; Kaltsas G; Randeva HS Eur J Clin Invest; 2018 Jul; 48(7):e12961. PubMed ID: 29845629 [TBL] [Abstract][Full Text] [Related]
8. Increased micronucleus, nucleoplasmic bridge, nuclear bud frequency and oxidative DNA damage associated with prolactin levels and pituitary adenoma diameters in patients with prolactinoma. Bitgen N; Donmez-Altuntas H; Bayram F; Cakir I; Hamurcu Z; Diri H; Baskol G; Senol S; Durak AC Biotech Histochem; 2016; 91(2):128-36. PubMed ID: 26720589 [TBL] [Abstract][Full Text] [Related]
11. Role of defective dopaminergic inhibition of prolactin secretion in the pathogenesis of prolactinoma. Vertosick FT Neurosurgery; 1985 Feb; 16(2):261-6. PubMed ID: 3974842 [TBL] [Abstract][Full Text] [Related]
12. Simulation of a prolactin-secreting adenoma by an intrasellar craniopharyngioma. Gamblin GT; James LP; Thomas J; Six E; Eil C Neurosurgery; 1985 May; 16(5):689-92. PubMed ID: 4039804 [TBL] [Abstract][Full Text] [Related]
13. An unusual course of prolactinoma during two consecutive pregnancies. Cohen I; Blankstein J; Oelsner G; Lunenfeld B; Berezin M Eur J Obstet Gynecol Reprod Biol; 1984 Sep; 18(1-2):81-4. PubMed ID: 6500151 [TBL] [Abstract][Full Text] [Related]
15. Long-term treatment of prolactin-secreting macroadenomas with pergolide. Freda PU; Andreadis CI; Khandji AG; Khoury M; Bruce JN; Jacobs TP; Wardlaw SL J Clin Endocrinol Metab; 2000 Jan; 85(1):8-13. PubMed ID: 10634356 [No Abstract] [Full Text] [Related]
16. Microsurgical management of prolactinomas - clinical and hormonal outcomes. Vivekanandan S; Nayak D Neurol India; 2011; 59(6):944-5. PubMed ID: 22234233 [No Abstract] [Full Text] [Related]
17. Treatment of presumed prolactinoma by transsphenoidal operation: early and late results. Thomson JA; Teasdale GM; Gordon D; McCruden DC; Davies DL Br Med J (Clin Res Ed); 1985 Nov; 291(6508):1550-3. PubMed ID: 3933747 [TBL] [Abstract][Full Text] [Related]